..............page:1229-1231
..............page:1225-1228
..............page:1185-1188
..............page:1240-1242+1249
..............page:1099-1106
..............page:1146-1150
..............page:1127-1131
..............page:1213-1216
..............page:1151-1154
..............page:1111-1116
..............page:1160-1164
..............page:1207-1212
..............page:1250-1252
..............page:1246-1249
..............page:1199-1202
..............page:1221-1224
..............page:1217-1220
..............page:1194-1198
..............page:1155-1159
..............page:1189-1193
..............page:1236-1239
..............page:1122-1126
..............page:1141-1145
..............page:1165-1168
..............page:1169-1172
qin cai su dui ren fei ai nci-h460 xi bao zeng zhi ji diao wang de ying xiang
PAN Xuediao 1;YANG Zhouping 1;YANG Zhiying 3;ZHOU Sigui 1;ZHANG Haitao 1;ZANG Linquan 1;2 1 Department of Pharmacology;New Drug Screening and Pharmacodynamics Evaluation Center;College of Pharmacy;Guangdong Pharmaceutical University;Guangzhou 510006;China;2 Guangdong Key Laboratory of Molecular Epidemiology;Guangdong Pharmaceutical University;Guangzhou 510310;China;3 Nutritional Department;Shenzhen Second People’s Hospital;Shenzhen 518035;China
..............page:1137-1140
..............page:1243-1245
..............page:1117-1121
..............page:1203-1206
..............page:1181-1184
..............page:1232-1235+1239
..............page:1107-1110
..............page:1173-1176
..............page:1132-1136
..............page:1177-1180